-
Smegglutide oral drug "Novoxin" has been approved in China, but it is not a "popular weight loss drug" on the internet
On January 26, Novo Nordisk Megglutide Tablets were approved by the National Drug Administration (NMPA) for marketing to treat type 2 diabetes. This is the first domestically approved oral GLP-1 (glu ...